Literature DB >> 3422174

Disseminated Trichosporon capitatum infection in a patient with acute leukemia.

T Ito1, Y Ishikawa, R Fujii, T Hattori, M Konno, S Kawakami, M Kosakai.   

Abstract

Disseminated Trichosporon capitatum infection in a 14-year-old boy with acute lymphoblastic leukemia is described. T. capitatum causes opportunistic infection in immunocompromised hosts.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3422174     DOI： 10.1002/1097-0142(19880201)61:3<585::aid-cncr2820610327>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  5 in total

1.  Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis.

Authors:  E J Anaissie; R Hachem; N C Karyotakis; A Gokaslan; M C Dignani; L C Stephens; C K Tin-U
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

Review 2.  Disseminated Blastoschizomyces capitatus infection in acute myeloblastic leukaemia. Report of three cases.

Authors:  M A Sanz; F López; M L Martínez; G F Sanz; J A Martínez; G Martín; M Gobernado
Journal:  Support Care Cancer       Date:  1996-07       Impact factor: 3.603

3.  Endocarditis caused by Blastoschizomyces capitatus and taxonomic review of the genus.

Authors:  I Polacheck; I F Salkin; R Kitzes-Cohen; R Raz
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

Review 4.  Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature.

Authors:  Aygul Dogan Celik; Resat Ozaras; Serda Kantarcioglu; Ali Mert; Fehmi Tabak; Recep Ozturk
Journal:  Rheumatol Int       Date:  2009-04-16       Impact factor: 2.631

5.  Osteomyelitis and intervertebral discitis caused by Blastoschizomyces capitatus in a patient with acute leukemia.

Authors:  D D'Antonio; R Piccolomini; G Fioritoni; A Iacone; S Betti; P Fazii; A Mazzoni
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.